Accenture logged a -4.7% change during today's afternoon session, and is now trading at a price of $337.48 per share.

Playtika sees this acquisition as a key move in strengthening its leadership in mobile gaming, driving growth with scaled titles, and unlocking new opportunities. The proposed transaction structure ...

Fortive has growing revenues and increasing reinvestment in the business and an excellent current ratio of 2.05. Additionally, the company's financial statements display wider gross margins than its ...

After this morning's 1.1% surge to $196.75 per share, Old Dominion Freight Line might just keep moving past its target price of $197.62. With an average analyst rating of buy, and target prices from ...

What Are the Fundamentals Of WM?

In the 10-K report, Campbell Soup discusses its strategic initiatives for 2024, emphasizing its focus on driving growth in its North American divisions and delivering on the promise of connecting ...

The market seems to share this rosy outlook, since Anheuser-Busch InBev has a short interest of only 0.3%. This represents the percentage of the share float that is being shorted, and each short ...

Steelcase Inc. (NYSE: SCS) has reported its second quarter fiscal 2025 results, highlighting strong performance compared to the prior year. The company's operating income increased by $49 million, ...

In terms of subscription metrics, SiriusXM saw a 25% increase in total paid subscribers, reaching 33 million in the second quarter of 2024. The company also reported a 21% churn rate and a gross ...

Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the strategy, the shares are purchased at a lower price at some time in the future.

Rocketing to a price of $105.55 during today's morning trading session, shares of ConocoPhillips are still -24.07% below their average target price of $139.01. Could there be more upside potential for ...

Labcorp, a global leader of innovative and comprehensive laboratory services, has over 67,000 employees serving clients in approximately 100 countries, providing support for 84% of the new drugs and ...